替格瑞洛的ChampionPhoenixIII期临床试验结果.pptVIP

48-Hour Events PLATFORM OR [95% CI] P value Death/MI/IDR 0.87 (0.71,1.07) 0.17 Death/Q-MI/IDR 0.55 (0.33,0.93) 0.02 Death/Q-MI/ST 0.38 (0.20,0.72) 0.003 PCI Death/MI/IDR 1.05 (0.89,1.24) 0.57 Death/Q-MI/IDR 0.66 (0.42,1.05) 0.08 Death/Q-MI/ST 0.74 (0.43,1.27) 0.27 POOLED Death/MI/IDR 0.97 (0.86,1.11) 0.68 Death/Q-MI/IDR 0.61 (0.43,0.86) 0.005 Death/Q-MI/ST 0.55 (0.36,0.83) 0.004 Cangrelor Better 5.0 2.0 1.0 0.2 0.5 Comparator Better Summary of Clinical Efficacy 1. Bhatt DL, Lincoff AM, Gibson CM, et al. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med 2009;361:233